Patheon, a leading global provider of high-quality drug development and manufacturing services, is headquartered in the United States. Founded in 1974, the company has established a strong presence in key operational regions, including Europe and Asia, serving clients across the pharmaceutical and biotechnology industries. Specialising in integrated solutions, Patheon offers a comprehensive range of services, from drug development and clinical trial support to commercial manufacturing. Their unique approach combines advanced technology with deep industry expertise, ensuring efficient and reliable production processes. Recognised for its commitment to quality and innovation, Patheon has achieved significant milestones, including numerous successful product launches and partnerships with major pharmaceutical companies. With a robust market position, Patheon continues to be a trusted partner in the evolving landscape of drug development and manufacturing.
How does Patheon's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Patheon's score of 10 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Patheon, headquartered in the US, currently does not provide specific carbon emissions data or reduction targets. Without available emissions figures, it is challenging to assess their carbon footprint or climate commitments accurately. However, the company is expected to align with industry standards and best practices regarding climate action. As the biopharmaceutical sector increasingly focuses on sustainability, Patheon may be exploring initiatives to reduce its environmental impact in line with broader industry trends. Further information on their climate commitments or specific reduction initiatives would be necessary to provide a comprehensive overview.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Patheon is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.